Skip to main content
. 2021 Feb 5;13(2):220. doi: 10.3390/pharmaceutics13020220

Figure 7.

Figure 7

Plasma ALZ sulfoxide concentration profiles after oral administration of crystalline ALZ and its ASDs in beagle dogs at a dose of 10 mg/kg (n = 3). Formulations were administered as capsules unless otherwise noted as suspension. Symbols: crystalline ALZ (), PVPVA ASD (), HPMCAS ASD (), HPMCAS ASD (suspension) (), Eudragit ASD ().